Marie A Bakitas1,2, J Nicholas Dionne-Odom1,2, Deborah B Ejem1,3, Rachel Wells1, Andres Azuero1, Macy L Stockdill1, Konda Keebler1, Elizabeth Sockwell1,2, Sheri Tims1,2, Sally Engler1, Karen Steinhauser4,5,6, Elizabeth Kvale7, Raegan W Durant3, Rodney O Tucker2, Kathryn L Burgio2,8, Jose Tallaj9, Keith M Swetz2,9, Salpy V Pamboukian9. 1. School of Nursing, University of Alabama at Birmingham, Birmingham. 2. Division of Gerontology, Geriatrics and Palliative Care, UAB Center for Palliative and Supportive Care, Department of Medicine, University of Alabama at Birmingham, Birmingham. 3. Division of Preventive Medicine, Department of Medicine, University of Alabama at Birmingham, Birmingham. 4. Center for Innovation, Veterans Affairs Medical Center, Durham, North Carolina. 5. Department of Population Health Sciences, Division of General Internal Medicine, Duke University, Durham, North Carolina. 6. Department of Medicine, Division of General Internal Medicine, Duke University, Durham, North Carolina. 7. Department of Medicine, Dell Medical School, University of Texas at Austin, Austin. 8. Geriatric Research, Education, and Clinical Center, Birmingham Veterans Affairs Medical Center, Birmingham, Alabama. 9. Division of Cardiovascular Diseases, Department of Medicine, University of Alabama at Birmingham, Birmingham.
Abstract
Importance: National guidelines recommend early palliative care for patients with advanced heart failure, which disproportionately affects rural and minority populations. Objective: To determine the effect of an early palliative care telehealth intervention over 16 weeks on the quality of life, mood, global health, pain, and resource use of patients with advanced heart failure. Design, Setting, and Participants: A single-blind, intervention vs usual care randomized clinical trial was conducted from October 1, 2015, to May 31, 2019, among 415 patients 50 years or older with New York Heart Association class III or IV heart failure or American College of Cardiology stage C or D heart failure at a large Southeastern US academic tertiary medical center and a Veterans Affairs medical center serving high proportions of rural dwellers and African American individuals. Interventions: The ENABLE CHF-PC (Educate, Nurture, Advise, Before Life Ends Comprehensive Heartcare for Patients and Caregivers) intervention comprises an in-person palliative care consultation and 6 weekly nurse-coach telephonic sessions (20-40 minutes) and monthly follow-up for 48 weeks. Main Outcomes and Measures: Primary outcomes were quality of life (as measured by the Kansas City Cardiomyopathy Questionnaire [KCCQ]: score range, 0-100; higher scores indicate better perceived health status and clinical summary scores ≥50 are considered "fairly good" quality of life; and the Functional Assessment of Chronic Illness Therapy-Palliative-14 [FACIT-Pal-14]: score range, 0-56; higher scores indicate better quality of life) and mood (as measured by the Hospital Anxiety and Depression Scale [HADS]) over 16 weeks. Secondary outcomes were global health (Patient Reported Outcome Measurement System Global Health), pain (Patient Reported Outcome Measurement System Pain Intensity and Interference), and resource use (hospital days and emergency department visits). Results: Of 415 participants (221 men; baseline mean [SD] age, 63.8 [8.5] years) randomized to ENABLE CHF-PC (n = 208) or usual care (n = 207), 226 (54.5%) were African American, 108 (26.0%) lived in a rural area, and 190 (45.8%) had a high-school education or less, and a mean (SD) baseline KCCQ score of 52.6 (21.0). At week 16, the mean (SE) KCCQ score improved 3.9 (1.3) points in the intervention group vs 2.3 (1.2) in the usual care group (difference, 1.6; SE, 1.7; d = 0.07 [95% CI, -0.09 to 0.24]) and the mean (SE) FACIT-Pal-14 score improved 1.4 (0.6) points in the intervention group vs 0.2 (0.5) points in the usual care group (difference, 1.2; SE, 0.8; d = 0.12 [95% CI, -0.03 to 0.28]). There were no relevant between-group differences in mood (HADS-anxiety, d = -0.02 [95% CI, -0.20 to 0.16]; HADS-depression, d = -0.09 [95% CI, -0.24 to 0.06]). Conclusions and Relevance: This randomized clinical trial with a majority African American sample and baseline good quality of life did not demonstrate improved quality of life or mood with a 16-week early palliative care telehealth intervention. However, pain intensity and interference (secondary outcomes) demonstrated a clinically important improvement. Trial Registration: ClinicalTrials.gov Identifier: NCT02505425.
RCT Entities:
Importance: National guidelines recommend early palliative care for patients with advanced heart failure, which disproportionately affects rural and minority populations. Objective: To determine the effect of an early palliative care telehealth intervention over 16 weeks on the quality of life, mood, global health, pain, and resource use of patients with advanced heart failure. Design, Setting, and Participants: A single-blind, intervention vs usual care randomized clinical trial was conducted from October 1, 2015, to May 31, 2019, among 415 patients 50 years or older with New York Heart Association class III or IV heart failure or American College of Cardiology stage C or D heart failure at a large Southeastern US academic tertiary medical center and a Veterans Affairs medical center serving high proportions of rural dwellers and African American individuals. Interventions: The ENABLE CHF-PC (Educate, Nurture, Advise, Before Life Ends Comprehensive Heartcare for Patients and Caregivers) intervention comprises an in-person palliative care consultation and 6 weekly nurse-coach telephonic sessions (20-40 minutes) and monthly follow-up for 48 weeks. Main Outcomes and Measures: Primary outcomes were quality of life (as measured by the Kansas City Cardiomyopathy Questionnaire [KCCQ]: score range, 0-100; higher scores indicate better perceived health status and clinical summary scores ≥50 are considered "fairly good" quality of life; and the Functional Assessment of Chronic Illness Therapy-Palliative-14 [FACIT-Pal-14]: score range, 0-56; higher scores indicate better quality of life) and mood (as measured by the Hospital Anxiety and Depression Scale [HADS]) over 16 weeks. Secondary outcomes were global health (Patient Reported Outcome Measurement System Global Health), pain (Patient Reported Outcome Measurement System Pain Intensity and Interference), and resource use (hospital days and emergency department visits). Results: Of 415 participants (221 men; baseline mean [SD] age, 63.8 [8.5] years) randomized to ENABLE CHF-PC (n = 208) or usual care (n = 207), 226 (54.5%) were African American, 108 (26.0%) lived in a rural area, and 190 (45.8%) had a high-school education or less, and a mean (SD) baseline KCCQ score of 52.6 (21.0). At week 16, the mean (SE) KCCQ score improved 3.9 (1.3) points in the intervention group vs 2.3 (1.2) in the usual care group (difference, 1.6; SE, 1.7; d = 0.07 [95% CI, -0.09 to 0.24]) and the mean (SE) FACIT-Pal-14 score improved 1.4 (0.6) points in the intervention group vs 0.2 (0.5) points in the usual care group (difference, 1.2; SE, 0.8; d = 0.12 [95% CI, -0.03 to 0.28]). There were no relevant between-group differences in mood (HADS-anxiety, d = -0.02 [95% CI, -0.20 to 0.16]; HADS-depression, d = -0.09 [95% CI, -0.24 to 0.06]). Conclusions and Relevance: This randomized clinical trial with a majority African American sample and baseline good quality of life did not demonstrate improved quality of life or mood with a 16-week early palliative care telehealth intervention. However, pain intensity and interference (secondary outcomes) demonstrated a clinically important improvement. Trial Registration: ClinicalTrials.gov Identifier: NCT02505425.
Authors: Suzanne V Arnold; Zhuokai Li; Sreekanth Vemulapalli; Suzanne J Baron; Michael J Mack; Andrzej S Kosinski; Matthew R Reynolds; James B Hermiller; John S Rumsfeld; David J Cohen Journal: JAMA Cardiol Date: 2018-12-01 Impact factor: 14.676
Authors: J Nicholas Dionne-Odom; Andres Azuero; Kathleen D Lyons; Jay G Hull; Tor Tosteson; Zhigang Li; Zhongze Li; Jennifer Frost; Konstantin H Dragnev; Imatullah Akyar; Mark T Hegel; Marie A Bakitas Journal: J Clin Oncol Date: 2015-03-23 Impact factor: 44.544
Authors: Marie Bakitas; Marguerite Stevens; Tim Ahles; Marie Kirn; Karen Skalla; Nancy Kane; E Robert Greenberg Journal: J Palliat Med Date: 2004-04 Impact factor: 2.947
Authors: Javed Butler; Muhammad Shahzeb Khan; Claudio Mori; Gerasimos S Filippatos; Piotr Ponikowski; Josep Comin-Colet; Bernard Roubert; John A Spertus; Stefan D Anker Journal: Eur J Heart Fail Date: 2020-04-02 Impact factor: 15.534
Authors: Rachel Wells; Macy L Stockdill; J Nicholas Dionne-Odom; Deborah Ejem; Kathryn L Burgio; Raegan W Durant; Sally Engler; Andres Azuero; Salpy V Pamboukian; Jose Tallaj; Keith M Swetz; Elizabeth Kvale; Rodney O Tucker; Marie Bakitas Journal: Trials Date: 2018-08-06 Impact factor: 2.279
Authors: J Nicholas Dionne-Odom; Deborah B Ejem; Rachel Wells; Andres Azuero; Macy L Stockdill; Konda Keebler; Elizabeth Sockwell; Sheri Tims; Sally Engler; Elizabeth Kvale; Raegan W Durant; Rodney O Tucker; Kathryn L Burgio; Jose Tallaj; Salpy V Pamboukian; Keith M Swetz; Marie A Bakitas Journal: JAMA Netw Open Date: 2020-04-01
Authors: Mary Pilar Ingle; Devon Check; Daniel Hogan Slack; Sarah H Cross; Natalie C Ernecoff; Daniel D Matlock; Dio Kavalieratos Journal: J Pain Symptom Manage Date: 2021-10-29 Impact factor: 3.612
Authors: Manjula Kurella Tamura; Laura Holdsworth; Margaret Stedman; Annette Aldous; Steven M Asch; Jialin Han; Glenda Harbert; Karl A Lorenz; Elizabeth Malcolm; Amanda Nicklas; Alvin H Moss; Dale E Lupu Journal: Clin J Am Soc Nephrol Date: 2022-09-14 Impact factor: 10.614
Authors: Rachel Wells; James Nicholas Dionne-Odom; Andres Azuero; Harleah Buck; Deborah Ejem; Kathryn L Burgio; Macy L Stockdill; Rodney Tucker; Salpy V Pamboukian; Jose Tallaj; Sally Engler; Konda Keebler; Sheri Tims; Raegan Durant; Keith M Swetz; Marie Bakitas Journal: J Pain Symptom Manage Date: 2021-02-05 Impact factor: 5.576
Authors: Shelli L Feder; Janet Tate; Mary Ersek; Supriya Krishnan; Sarwat I Chaudhry; Lori A Bastian; Joshua Rolnick; Ann Kutney-Lee; Kathleen M Akgün Journal: J Pain Symptom Manage Date: 2020-09-12 Impact factor: 3.612
Authors: Kristen Allen Watts; Emily Malone; J Nicholas Dionne-Odom; Susan McCammon; Erin Currie; Jennifer Hicks; Rodney O Tucker; Eric Wallace; Ronit Elk; Marie Bakitas Journal: Res Nurs Health Date: 2021-01-04 Impact factor: 2.228